Asset Allocation

As of February 28, 2026.
Type % Net
Cash 0.98%
Stock 65.56%
Bond 32.17%
Convertible 0.00%
Preferred 0.00%
Other 1.29%
View Asset Allocation
Start Trial

Market Capitalization

As of February 28, 2026
Large 91.80%
Mid 5.59%
Small 2.61%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 97.58%    % Emerging Markets: 0.24%    % Unidentified Markets: 2.18%

Americas 89.05%
88.95%
Canada 71.88%
United States 17.07%
0.09%
As of February 28, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 6.39%
United Kingdom 1.17%
5.14%
Denmark 0.01%
France 0.87%
Germany 0.30%
Ireland 0.00%
Italy 1.04%
Netherlands 0.87%
Spain 1.02%
Switzerland 0.61%
0.07%
Czech Republic 0.07%
0.00%
Greater Asia 2.38%
Japan 2.38%
0.00%
0.00%
0.00%
Unidentified Region 2.18%

Bond Credit Quality Exposure

AAA 0.32%
AA 3.55%
A 32.14%
BBB 38.63%
BB 3.67%
B 0.85%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.47%
Not Available 19.36%
Short Term 0.00%
As of February 28, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
54.02%
Materials
15.63%
Consumer Discretionary
6.82%
Financials
30.27%
Real Estate
1.30%
Sensitive
30.64%
Communication Services
0.86%
Energy
8.41%
Industrials
12.31%
Information Technology
9.08%
Defensive
10.46%
Consumer Staples
3.56%
Health Care
5.16%
Utilities
1.75%
Not Classified
4.87%
Non Classified Equity
4.13%
Not Classified - Non Equity
0.74%
As of February 28, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of February 28, 2026
Type % Net
Government 1.68%
Corporate 72.47%
Securitized 0.59%
Municipal 2.75%
Other 22.52%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.26%
Less than 1 Year
0.26%
Intermediate
74.32%
1 to 3 Years
18.51%
3 to 5 Years
12.02%
5 to 10 Years
43.80%
Long Term
24.55%
10 to 20 Years
7.38%
20 to 30 Years
12.04%
Over 30 Years
5.12%
Other
0.87%
As of February 28, 2026
View Bond Maturity Exposure
Start Trial